Literature DB >> 15780807

Comparison of transcription mediated amplification (TMA) and reverse transcription polymerase chain reaction (RT-PCR) for detection of hepatitis C virus RNA in liver tissue.

Wolf Peter Hofmann1, Volker Dries, Eva Herrmann, Barbara Gärtner, Stefan Zeuzem, Christoph Sarrazin.   

Abstract

BACKGROUND: Transcription mediated amplification (TMA) is known to be one of the most sensitive detection assays for hepatitis C virus (HCV) RNA in serum but has not yet been evaluated in liver tissue. It is unknown whether the higher sensitivity of TMA in comparison with polymerase chain reaction (PCR)-based assays is related to a higher efficiency of the extraction and/or amplification step.
OBJECTIVES: The sensitivity of a TMA-based assay (Versant HCV RNA Qualitative assay, Bayer Diagnostics) and a standard RT-PCR-based assay (Cobas Amplicor HCV 2.0, Roche Diagnostics) was compared in formalin-fixed paraffin-embedded liver biopsy specimens of patients with chronic hepatitis C. STUDY
DESIGN: After deparaffinization of 7.5 microm liver sections HCV RNA was extracted by standard phenol/chloroform. HCV RNA dilution panels were transferred in parallel to cDNA synthesis and amplification steps of PCR and TMA. Furthermore, TMA amplification from stepwise diluted HCV sera was performed following RNA extraction by either microcentrifuge colums (QIAmp Viral RNA spin Kit, Qiagen, Hilden, Germany) or magnetic microparticles (VERSANT HCV RNA Qualitative assay).
RESULTS: The total number of HCV RNA positive liver specimens detected by TMA was higher compared with those detected by RT-PCR (P=0.032). The total number of TMA positive serum samples was higher when HCV RNA was extracted using magnetic microparticles in comparison with multicentrifuge column extraction (P=0.019).
CONCLUSION: Our results suggest that both the extraction and amplification step of the TMA-based assay contribute to the higher sensitivity compared with standard RT-PCR.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15780807     DOI: 10.1016/j.jcv.2004.08.011

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  15 in total

1.  Sicca syndrome and dementia in a patient with hepatitis C infection: a case report with unusual bifocal extrahepatic manifestations.

Authors:  R H Khonsari; S Maylin; P Nicol; M Martinot-Peignoux; A Créange; C Duyckaerts; C Bertolus
Journal:  J Maxillofac Oral Surg       Date:  2014-06-05

2.  Helicase-Dependent Isothermal Amplification of DNA and RNA by Using Self-Avoiding Molecular Recognition Systems.

Authors:  Zunyi Yang; Chris McLendon; Daniel Hutter; Kevin M Bradley; Shuichi Hoshika; Carole B Frye; Steven A Benner
Journal:  Chembiochem       Date:  2015-05-07       Impact factor: 3.164

Review 3.  Diagnostic tests for hepatitis C: recent trends in electrochemical immunosensor and genosensor analysis.

Authors:  Carolina V Uliana; Carla S Riccardi; Hideko Yamanaka
Journal:  World J Gastroenterol       Date:  2014-11-14       Impact factor: 5.742

Review 4.  Point-of-care nucleic acid testing for infectious diseases.

Authors:  Angelika Niemz; Tanya M Ferguson; David S Boyle
Journal:  Trends Biotechnol       Date:  2011-03-04       Impact factor: 19.536

Review 5.  Molecular and antigen tests, and sample types for diagnosis of COVID-19: a review.

Authors:  Yujia Zhang; Rachael Garner; Sana Salehi; Marianna La Rocca; Dominique Duncan
Journal:  Future Virol       Date:  2022-07-01       Impact factor: 3.015

6.  Competitive reporter monitored amplification (CMA)--quantification of molecular targets by real time monitoring of competitive reporter hybridization.

Authors:  Thomas Ullrich; Eugen Ermantraut; Torsten Schulz; Katrin Steinmetzer
Journal:  PLoS One       Date:  2012-04-23       Impact factor: 3.240

7.  Sequence dependence of isothermal DNA amplification via EXPAR.

Authors:  Jifeng Qian; Tanya M Ferguson; Deepali N Shinde; Alissa J Ramírez-Borrero; Arend Hintze; Christoph Adami; Angelika Niemz
Journal:  Nucleic Acids Res       Date:  2012-03-13       Impact factor: 16.971

Review 8.  HCV Detection, Discrimination, and Genotyping Technologies.

Authors:  Shrikant Dashrath Warkad; Satish Balasaheb Nimse; Keum-Soo Song; Taisun Kim
Journal:  Sensors (Basel)       Date:  2018-10-12       Impact factor: 3.576

9.  Risk of SARS-CoV-2 Infection in Previously Infected and Non-Infected Cohorts of Health Workers at High Risk of Exposure.

Authors:  Adrián Sánchez-Montalvá; Candela Fernández-Naval; Andrés Antón; Xavier Durà; Alba Vimes; Aroa Silgado; Fernando Velásquez-Orozco; Juan Espinosa-Pereiro; Fernando Salvador; Tomás Pumarola; Benito Almirante; Juliana Esperalba
Journal:  J Clin Med       Date:  2021-05-04       Impact factor: 4.241

Review 10.  Diagnostic techniques for COVID-19 and new developments.

Authors:  Elham Sheikhzadeh; Shimaa Eissa; Aziah Ismail; Mohammed Zourob
Journal:  Talanta       Date:  2020-07-14       Impact factor: 6.057

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.